{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:51:49Z","timestamp":1760233909364,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:00:00Z","timestamp":1615075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The segmentation of the in vitro fertilization (IVF) cycle, consisting of the freezing of all embryos and the postponement of embryo transfer (ET), has become popular in recent years, with the main purpose of preventing ovarian hyperstimulation syndrome (OHSS) in patients with high response to controlled ovarian stimulation (COS). Indeed cycle segmentation (CS), especially when coupled to a GnRH-agonist trigger, was shown to reduce the incidence of OHSS in high-risk patients. However, CS increases the economic costs and the work amount for IVF laboratories. An alternative strategy is to perform a fresh ET in association with intensive luteal phase pharmacological support, able to overcome the negative effects of the GnRH-agonist trigger on the luteal phase and on endometrial receptivity. In order to compare these two strategies, we performed a retrospective, real-life cohort study including 240 non-polycystic ovarian syndrome (PCO) women with expected high responsiveness to COS (AMH &gt;2.5 ng\/mL), who received either fresh ET plus 100 IU daily human chorionic gonadotropin (hCG) as luteal support (FRESH group, n = 133), or cycle segmentation with freezing of all embryos and postponed ET (CS group, n = 107). The primary outcomes were: implantation rate (IR), live birth rate (LBR) after the first ET, and incidence of OHSS. Overall, significantly higher IR and LBR were observed in the CS group than in the FRESH group (42.9% vs. 27.8%, p &lt; 0.05 and 32.7% vs. 19.5%, p &lt; 0.05, respectively); the superiority of CS strategy was particularly evident when 16\u201319 oocytes were retrieved (LBR 42.2% vs. 9.5%, p = 0.01). Mild OHSS appeared with the same incidence in the two groups, whereas moderate and severe OHSS forms were observed only in the FRESH group (1.5% and 0.8%, respectively). In conclusion, in non-PCO women, high responders submitted to COS with the GnRH-antagonist protocol and GnRH-agonist trigger, CS strategy was associated with higher IR and LBR than the strategy including fresh ET followed by luteal phase support with a low daily hCG dose. CS appears to be advisable, especially when &gt;15 oocytes are retrieved.<\/jats:p>","DOI":"10.3390\/ph14030228","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T21:52:15Z","timestamp":1615153935000},"page":"228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-4499","authenticated-orcid":false,"given":"Andrea Roberto","family":"Carosso","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-6750","authenticated-orcid":false,"given":"Stefano","family":"Canosa","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-9428","authenticated-orcid":false,"given":"Gianluca","family":"Gennarelli","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Sestero","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Evangelisti","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-4508","authenticated-orcid":false,"given":"Lorena","family":"Charrier","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatrics, University of Torino, Via Santena, 5 bis, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-7340","authenticated-orcid":false,"given":"Loredana","family":"Bergandi","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Via Santena 5 bis, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-3722","authenticated-orcid":false,"given":"Alberto","family":"Revelli","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant\u2019Anna Hospital, University of Torino, 10042 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2008.07.1745","article-title":"The Human Corpus Luteum: Life Cycle and Function in Natural Cycles","volume":"92","author":"Devoto","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1472-6483(10)61729-4","article-title":"Luteinizing Hormone Affects Uterine Receptivity Independently of Ovarian Function","volume":"7","author":"Tesarik","year":"2003","journal-title":"Reprod. Biomed. Online"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0015-0282(16)60906-8","article-title":"Disappearance of Exogenously Administered Human Chorionic Gonadotropin","volume":"52","author":"Damewood","year":"1989","journal-title":"Fertil. Steril."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0015-0282(03)00789-1","article-title":"Effect of Human Chorionic Gonadotropin on Luteal Luteinizing Hormone Concentrations in Natural Cycles","volume":"80","author":"Tavaniotou","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1043-2760(03)00075-4","article-title":"Reproductive Biology and IVF: Ovarian Stimulation and Luteal Phase Consequences","volume":"14","author":"Fauser","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","article-title":"The Luteal Phase after GnRH-Agonist Triggering of Ovulation: Present and Future Perspectives","volume":"24","author":"Humaidan","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Van der Linden, M., Buckingham, K., Farquhar, C., Kremer, J.A.M., and Metwally, M. (2015). Luteal Phase Support for Assisted Reproduction Cycles. Cochrane Database Syst. Rev., CD009154.","DOI":"10.1002\/14651858.CD009154.pub3"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian Hormone (AMH) as a Predictive Marker in Assisted Reproductive Technology (ART)","volume":"16","author":"Sighinolfi","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"ref_9","first-page":"1967","article-title":"Human Chorionic Gonadotropin-Dependent Expression of Vascular Endothelial Growth Factor\/Vascular Permeability Factor in Human Granulosa Cells: Importance in Ovarian Hyperstimulation Syndrome","volume":"80","author":"Neulen","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/molehr\/8.5.409","article-title":"The Role of Endothelial Cells in the Pathogenesis of Ovarian Hyperstimulation Syndrome","volume":"8","author":"Albert","year":"2002","journal-title":"Mol. Hum. Reprod."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"Copenhagen GnRH Agonist Triggering Workshop Group GnRH Agonist for Triggering of Final Oocyte Maturation: Time for a Change of Practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/deh613","article-title":"Can We Eliminate Severe Ovarian Hyperstimulation Syndrome?","volume":"20","author":"Orvieto","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/humrep\/dem006","article-title":"Elective Cryopreservation of All Pronuclear Oocytes after GnRH Agonist Triggering of Final Oocyte Maturation in Patients at Risk of Developing OHSS: A Prospective, Observational Proof-of-Concept Study","volume":"22","author":"Griesinger","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent High Clinical Pregnancy Rates and Low Ovarian Hyperstimulation Syndrome Rates in High-Risk Patients after GnRH Agonist Triggering and Modified Luteal Support: A Retrospective Multicentre Study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH Agonist (Buserelin) or HCG for Ovulation Induction in GnRH Antagonist IVF\/ICSI Cycles: A Prospective Randomized Study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum. Reprod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by Segmentation of IVF Treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.fertnstert.2004.11.055","article-title":"Optimization of Estradiol Supplementation during the Luteal Phase Improves the Pregnancy Rate in Women Undergoing in Vitro Fertilization-Embryo Transfer Cycles","volume":"83","author":"Lukaszuk","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/14647273.2016.1200145","article-title":"Luteal Phase Support with Estradiol and Progesterone versus Progesterone Alone in GnRH Antagonist ICSI Cycles: A Randomized Controlled Study","volume":"19","author":"Noah","year":"2016","journal-title":"Hum. Fertil. (Camb)"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Santos-Ribeiro, S., Mackens, S., Popovic-Todorovic, B., Racca, A., Polyzos, N.P., Van Landuyt, L., Drakopoulos, P., de Vos, M., Tournaye, H., and Blockeel, C. (2020). The Freeze-All Strategy versus Agonist Triggering with Low-Dose HCG for Luteal Phase Support in IVF\/ICSI for High Responders: A Randomized Controlled Trial. Hum. Reprod.","DOI":"10.1093\/humrep\/deaa226"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-016-0764-7","article-title":"Micro-Dose HCG as Luteal Phase Support without Exogenous Progesterone Administration: Mathematical Modelling of the HCG Concentration in Circulation and Initial Clinical Experience","volume":"33","author":"Andersen","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10815-014-0391-0","article-title":"Freeze-All Policy: Is It Time for That?","volume":"32","author":"Roque","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/OGX.0000000000000432","article-title":"Gonadotropin-Releasing Hormone-Agonist Triggering and a Freeze-All Approach: The Final Step in Eliminating Ovarian Hyperstimulation Syndrome?","volume":"72","author":"Davenport","year":"2017","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2018.05.024","article-title":"Freezing of All Embryos in in Vitro Fertilization Is Beneficial in High Responders, but Not Intermediate and Low Responders: An Analysis of 82,935 Cycles from the Society for Assisted Reproductive Technology Registry","volume":"110","author":"Acharya","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.rbmo.2017.04.012","article-title":"Empty Follicle Syndrome Revisited: Definition, Incidence, Aetiology, Early Diagnosis and Treatment","volume":"35","author":"Revelli","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/humupd\/dmu027","article-title":"Fresh versus Frozen Embryo Transfer: Backing Clinical Decisions with Scientific and Clinical Evidence","volume":"20","author":"Evans","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of Gonadotropin-Releasing Hormone Agonist to Trigger Follicular Maturation for in Vitro Fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone Elevation and Probability of Pregnancy after IVF: A Systematic Review and Meta-Analysis of over 60 000 Cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/humrep\/dep039","article-title":"Gene Expression Profile of Human Endometrial Receptivity: Comparison between Natural and Stimulated Cycles for the Same Patients","volume":"24","author":"Haouzi","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/humrep\/des386","article-title":"Elective Frozen Replacement Cycles for All: Ready for Prime Time?","volume":"28","author":"Maheshwari","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/humrep\/dep046","article-title":"Pregnancies Conceived Using Assisted Reproductive Technologies (ART) Have Low Levels of Pregnancy-Associated Plasma Protein-A (PAPP-A) Leading to a High Rate of False-Positive Results in First Trimester Screening for Down Syndrome","volume":"24","author":"Amor","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Carosso, A., Revelli, A., Gennarelli, G., Canosa, S., Cosma, S., Borella, F., Tancredi, A., Paschero, C., Boatti, L., and Zanotto, E. (2020). Controlled Ovarian Stimulation and Progesterone Supplementation Affect Vaginal and Endometrial Microbiota in IVF Cycles: A Pilot Study. J. Assist. Reprod. Genet.","DOI":"10.1007\/s10815-020-01878-4"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10815-016-0834-x","article-title":"Freeze-All Cycle for All Normal Responders?","volume":"34","author":"Roque","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.fertnstert.2010.05.049","article-title":"Perinatal Morbidity after in Vitro Fertilization Is Lower with Frozen Embryo Transfer","volume":"95","author":"Ratcliffe","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.fertnstert.2017.10.019","article-title":"Pregnancy-Related Complications and Perinatal Outcomes Resulting from Transfer of Cryopreserved versus Fresh Embryos in Vitro Fertilization: A Meta-Analysis","volume":"109","author":"Sha","year":"2018","journal-title":"Fertil. Steril."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/humrep\/dev184","article-title":"Daily Low-Dose HCG Stimulation during the Luteal Phase Combined with GnRHa Triggered IVF Cycles without Exogenous Progesterone: A Proof of Concept Trial","volume":"30","author":"Andersen","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2009.02.066","article-title":"Serum Estradiol Levels during Controlled Ovarian Hyperstimulation Influence the Pregnancy Outcome of in Vitro Fertilization in a Concentration-Dependent Manner","volume":"93","author":"Joo","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.fertnstert.2020.04.004","article-title":"Ovarian Hyperstimulation Syndrome after Assisted Reproductive Technologies: Trends, Predictors, and Pregnancy Outcomes","volume":"114","author":"Schirmer","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"hoy021","DOI":"10.1093\/hropen\/hoy021","article-title":"Evidence Summaries and Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: Assessment and Treatment of Infertility","volume":"2019","author":"Costello","year":"2019","journal-title":"Hum. Reprod. Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/humrep\/del403","article-title":"Construction of an Evidence-Based Integrated Morphology Cleavage Embryo Score for Implantation Potential of Embryos Scored and Transferred on Day 2 after Oocyte Retrieval","volume":"22","author":"Holte","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"(2011). Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology The Istanbul Consensus Workshop on Embryo Assessment: Proceedings of an Expert Meeting. Hum. Reprod., 26, 1270\u20131283.","DOI":"10.1093\/humrep\/der037"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Revelli, A., Gennarelli, G., Biasoni, V., Chiad\u00f2, A., Carosso, A., Evangelista, F., Paschero, C., Filippini, C., and Benedetto, C. (2020). The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061914"},{"key":"ref_43","unstructured":"(2020, June 30). Ovarian Hyperstimulation Syndrome, Management (Green-Top Guideline No. 5). Available online: https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/gtg5\/."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/3\/228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:34:28Z","timestamp":1760160868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/3\/228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,7]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ph14030228"],"URL":"https:\/\/doi.org\/10.3390\/ph14030228","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2021,3,7]]}}}